LEMAITRE VASCULAR, INC. (LMAT) Operating margin 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) operating margin by fiscal year — reported operating income divided by reported revenue.
27.2%FY2025 · since FY2016: 18.3% → 27.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 27.2% | +3.4 pp |
| FY2024 | 23.8% | +4.8 pp |
| FY2023 | 19.0% | +2.4 pp |
| FY2022 | 16.6% | -7.0 pp |
| FY2021 | 23.6% | +1.3 pp |
| FY2020 | 22.3% | +4.2 pp |
| FY2019 | 18.1% | -8.7 pp |
| FY2018 | 26.7% | +5.8 pp |
| FY2017 | 20.9% | +2.6 pp |
| FY2016 | 18.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More LMAT financial trends
LMAT RevenueLMAT Net incomeLMAT Net marginLMAT Gross profitLMAT Gross marginLMAT Operating incomeLMAT Operating cash flowLMAT Free cash flowLMAT Capital expendituresLMAT Return on equityLMAT Stock buybacksLMAT Dividends paidLMAT Total assetsLMAT Total liabilitiesLMAT Shareholders’ equityLMAT overview →